Financial Performance

A new poll for America's 250th birthday shows a nation that reveres its Founders but has abandoned their core beliefs on rights and government.

With key data on its Duchenne muscular dystrophy drugs expected in 2026, Entrada's CEO Dipal Doshi will detail the firm's high-risk, high-reward strategy.

New 4-year real-world data shows Zevra's drug stabilizes the rare, fatal 'Childhood Alzheimer's' disease, marking a milestone for patients and families.

The firm's assets grew on market gains, but significant client outflows and shrinking fees triggered a sharp stock drop, revealing key industry pressures.

CDW announces a $0.630 quarterly dividend, marking 12 straight years of increases. Discover how its robust capital strategy fuels consistent investor returns.

With a key cancer drug awaiting FDA review and pivotal data imminent, Celcuity faces investors at a critical juncture. What will they be looking for?

With promising new pipeline data and a major earnings report looming, Aclaris Therapeutics heads to two investor summits, placing its strategy on display.

A major acquisition reshapes the shelf-stable food safety landscape, combining regulatory might with scientific expertise amid a booming market.

Fueled by strong investor demand, Meridian Mining has upsized its financing to C$50 million, accelerating its high-potential Cabaçal project in Brazil.

A new six-month injection for Central Precocious Puberty shows strong safety and efficacy, promising to ease the treatment burden for children and families.

A new partnership between HAESL and HCLTech will transform engine repair with real-time data, setting a new standard for the aviation MRO industry.

A new alliance between probate experts and tech innovators offers immediate cash and cuts administrative red tape for thousands of grieving UK families.

The entrepreneur is expanding his Mileo Hotels brand to Dominica and launching a new website, signaling a push into sustainable tourism and transparency.

Following a record-breaking 2025, Europe's top asset manager is launching a major share buyback to boost shareholder value and signal market confidence.

The Longines Hong Kong Horse Show blended Olympic-level sport with festive culture and pop entertainment, showcasing a new model for global mega-events.

A new review calls Webroot a top VPN, but independent tests and affiliate marketing models tell a more complex story. Here's what you need to know.

Pacaso is betting the ultra-wealthy will pay $100K to join an invitation-only club for swapping their multi-million dollar homes. Is this the future of luxury travel?

With its Q4 and full-year 2025 earnings call on the horizon, Cactus Inc.'s consistent dividend payout offers a glimpse into its financial stability.

As OneMain CEO Doug Shulman prepares for a key conference, all eyes are on the lender's strategy for navigating a complex economic and regulatory landscape.

Atlanticus Holdings Corp. confirms its quarterly preferred stock dividend, highlighting a rare blend of FinTech innovation with reliable investor returns.